Quest Diagnostics outlines earnings timetable, shares tracked against US diagnostics peers
Published on 06/26/2026 at 14:25 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
By Anna Wagner, Analysts & Consensus desk. Reviewed prior to publication on 2026-06-26, 14:25.
Quest Diagnostics (US74834L1008) sets the tone for NYSE investors with a clear timetable for its next financial updates. The diagnostics provider competes in the US with listed peers such as Labcorp and Abbott Laboratories, both part of the S&P 500 index.
What the calendar shows
Quest Diagnostics lists its quarterly earnings calls and investor conferences in the events section of its investor relations website, giving dates for upcoming presentations and webcasts for 2026. The group typically reports second-quarter figures in late July or early August, followed by a third-quarter update in late October.
For the most recent reported quarter, Quest Diagnostics posted revenue of around 2.4 billion USD and discussed trends in routine testing and esoteric diagnostics on its earnings call, according to company materials and analyst summaries.
How analysts value the stock
On the NYSE, Quest Diagnostics trades under the ticker DGX and closed the session of 2026-06-25 at roughly 206 USD, with a 52-week range from about 162 USD to just over 212 USD, according to recent market data.
Analyst data compiled by PandaForecast and other aggregators point to an average price expectation in the low-220 USD range for Quest Diagnostics, implying modest upside versus the latest close, while recent rating actions include at least one downgrade to Hold in May 2026 by Wall Street Zen.
Background and price data on Quest Diagnostics
News, key figures and historical data provide additional context for investors following Quest Diagnostics shares on the NYSE.
The business behind the ticker
Quest Diagnostics generates most of its revenue from diagnostic information services such as routine blood tests, advanced cardiovascular diagnostics and oncology-related testing. The company also offers anatomic pathology services and genomic sequencing in specialized laboratories across the United States.
Where the stock trades today
The Quest Diagnostics shares (US74834L1008) most recently traded on the NYSE at around 206 USD on 2026-06-25, according to recent closing data.
Key data on the Quest Diagnostics shares
- Company: Quest Diagnostics Incorporated
- ISIN: US74834L1008
- WKN: 918895
- Ticker: DGX
- Trading venue: NYSE
- Price (as of 2026-06-25, 21:59): 206.33 USD
- Market cap: 23.0 billion USD (as of 2026-06-25)
- Sector / industry: Health Care / Diagnostics & Research
- Index membership: S&P 500
- Next earnings date: not officially scheduled
Disclaimer: This article is for informational purposes only and does not constitute investment advice, an offer, or a solicitation to buy or sell any securities. Investors should conduct their own research and, where appropriate, consult a qualified financial advisor before making investment decisions.
Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.
